287 related articles for article (PubMed ID: 15011778)
1. Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines.
Karin N
Curr Opin Mol Ther; 2004 Feb; 6(1):27-33. PubMed ID: 15011778
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for T cell-mediated autoimmunity: teaching the immune system how to restrain its own harmful activities by targeted DNA vaccines.
Karin N
Isr Med Assoc J; 2000 Jul; 2 Suppl():63-8. PubMed ID: 10909420
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors.
Prud'homme GJ
J Gene Med; 2000; 2(4):222-32. PubMed ID: 10953913
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice.
Li AF; Hough J; Henderson D; Escher A
Vaccine; 2004 Apr; 22(13-14):1751-63. PubMed ID: 15068859
[TBL] [Abstract][Full Text] [Related]
5. Monocyte/macrophage initiation of organ-specific autoimmunity: the ultimate 'bystander' hypothesis?
Stoy NS
Med Hypotheses; 2002 Apr; 58(4):312-26. PubMed ID: 12027526
[TBL] [Abstract][Full Text] [Related]
6. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
[TBL] [Abstract][Full Text] [Related]
7. Cetirizine and allopurinol as novel weapons against cellular autoimmune disorders.
Namazi MR
Int Immunopharmacol; 2004 Mar; 4(3):349-53. PubMed ID: 15037212
[TBL] [Abstract][Full Text] [Related]
8. Millennium Award. Proteomics for the development of DNA tolerizing vaccines to treat autoimmune disease.
Robinson WH; Garren H; Utz PJ; Steinman L
Clin Immunol; 2002 Apr; 103(1):7-12. PubMed ID: 11987980
[TBL] [Abstract][Full Text] [Related]
9. Stress as an endogenous adjuvant: augmentation of the immunization phase of cell-mediated immunity.
Viswanathan K; Daugherty C; Dhabhar FS
Int Immunol; 2005 Aug; 17(8):1059-69. PubMed ID: 16000327
[TBL] [Abstract][Full Text] [Related]
10. [Blockade of chemokines in chronic inflammatory diseases].
Haringman JJ; Tak PP
Ned Tijdschr Geneeskd; 2004 Sep; 148(36):1760-4. PubMed ID: 15495938
[TBL] [Abstract][Full Text] [Related]
11. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
[TBL] [Abstract][Full Text] [Related]
12. Cytokines and autoimmunity.
O'Shea JJ; Ma A; Lipsky P
Nat Rev Immunol; 2002 Jan; 2(1):37-45. PubMed ID: 11905836
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune disorders, physical activity, and training, with particular reference to rheumatoid arthritis.
Shephard RJ; Shek PN
Exerc Immunol Rev; 1997; 3():53-67. PubMed ID: 9139753
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of natural immunity to a pro-inflammatory cytokine (TNF-alpha) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis.
Wildbaum G; Karin N
Gene Ther; 1999 Jun; 6(6):1128-38. PubMed ID: 10455416
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for arthritis.
Robbins PD; Evans CH; Chernajovsky Y
Gene Ther; 2003 May; 10(10):902-11. PubMed ID: 12732875
[TBL] [Abstract][Full Text] [Related]
16. Is damage in central nervous system due to inflammation?
Chavarria A; Alcocer-Varela J
Autoimmun Rev; 2004 Jun; 3(4):251-60. PubMed ID: 15246020
[TBL] [Abstract][Full Text] [Related]
17. Beneficial autoimmunity participates in the regulation of rheumatoid arthritis.
Zohar Y; Wildbaum G; Karin N
Front Biosci; 2006 Jan; 11():368-79. PubMed ID: 16146738
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for autoimmune diseases: quo vadis?
Chernajovsky Y; Gould DJ; Podhajcer OL
Nat Rev Immunol; 2004 Oct; 4(10):800-11. PubMed ID: 15459671
[TBL] [Abstract][Full Text] [Related]
19. FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro.
Novak N; Valenta R; Bohle B; Laffer S; Haberstok J; Kraft S; Bieber T
J Allergy Clin Immunol; 2004 May; 113(5):949-57. PubMed ID: 15131579
[TBL] [Abstract][Full Text] [Related]
20. Chemokines: immunology's high impact factors.
Mackay CR
Nat Immunol; 2001 Feb; 2(2):95-101. PubMed ID: 11175800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
